Antinuclear antibodies: When to test and how to interpret findings

Journal of Family Practice

Volumn 64, Issue 1, 2015, Pages E5-E8

  Rehman, Habib U ^a  

^a REGINA GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

ARTICLE; CALCINOSIS; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DISEASE ACTIVITY; DRY EYE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; MIXED CONNECTIVE TISSUE DISEASE; MUSCLE WEAKNESS; PATIENT MONITORING; PROGNOSIS; RASH; RAYNAUD PHENOMENON; BLOOD; CONNECTIVE TISSUE DISEASES; DISEASE COURSE; FLUORESCENT ANTIBODY TECHNIQUE; NEOPLASMS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

ANTIBODIES, ANTINUCLEAR; CONNECTIVE TISSUE DISEASES; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MIXED CONNECTIVE TISSUE DISEASE; NEOPLASMS; PROGNOSIS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84920731991     PISSN: 00943509     EISSN: 15337294     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Volkmann ER, Taylor M, Ben-Artzi A. Using the antinuclear antibody test to diagnose rheumatic disease: when does a positive test warrant further investigation? South Med J. 2012;105: 100-104.
2. Giannouli E, Chatzidimitriou D, Gerou S, et al. Frequency and specificity of antibodies against nuclear and cytoplasmic antigens in healthy individuals by classic and new methods. Clin Rheumatol. 2013;32:1541-1546.
3. O'Sullivan M, McLean-Tooke A, Loh RK. Antinuclear antibody test. Aust Fam Physician. 2013;42:718-721.
4. Kurien BT, Scofield RH. Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol. 2006;64:227-235.
5. Basu D, Reveille JD. Ant-scl-70. Autoimmunity. 2005;38: 65-72.
6. Caramaschi P, Biasi D, Manzo T, et al. Anticentromere antibody-clinical associations. A study of 44 patients. Rheumatol Int. 1995;14:253-255.
7. Migliorini P, Baldini C, Rocchi V, et al. Anti-Sm and anti-RNP antibodies. Autoimmunity. 2005;38:47-54.
8. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol. 1989;16:328-334.
9. Phan TG, Wong RC, Adelstein S. Autoantibodies to extractable nuclear antigens: making detection and interpretation more meaningful. Clin Diagn Lab Immunol. 2002;9:1-7.
10. Cross LS, Aslam A, Misbah SA. Antinuclear antibody-negative lupus as a distinct diagnostic entity-does it no longer exist? QJM. 2004;97:303-308.
11. Miller FW, Waite KA, Biswat T, et al. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci USA. 1990;87:9933-9937.
12. Brito-Zerón P, Ramos-Casals M, Bove A, et al. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology. 2007;46:1359-1362.
13. Lindop R, Arentz G, Thurgood LA, et al. Pathogenicity and proteomic signatures of autoantibodies to Ro and La. Immunol Cell Biol. 2012;90:304-309.
14. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35:35-42.
15. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med. 1998;158:595-600.
16. Grassi A, Corona F, Casellato A, et al. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease. J Rheumatol. 2007;34:1139-1145.
17. Petri M. Diagnosis of antiphospholipid antibody syndrome. Rheum Dis Clin North Am. 1994;20:443.
18. Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med. 2000;124:71-81.